Skip directly to page options Skip directly to A-Z link
Volume 30, Number 2—February 2024
Dispatch

Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004–2023

Lucas KhellafComments to Author , Virginie Lemiale, Maxens Decavèle, Marc Pineton de Chambrun, Alexandra Beurton, Toufik Kamel, Anabelle Stoclin, Djamel Mokart, Fabrice Bruneel, Clara Vigneron, Achille Kouatchet, Benoît Henry, Jean-Pierre Quenot, Grégoire Jolly, Nahema Issa, Matthieu Bellal, Julien Poissy, Claire Pichereau, Julien Schmidt, Nathalie Layios, Maxime Gaillet, Elie Azoulay, and Adrien Joseph
Author affiliations: Saint-Louis Teaching Hospital, Public Assistance Hospitals of Paris (APHP), Paris, France (L. Khellaf, V. Lemiale, E. Azoulay, A. Joseph); Pitié-Salpétière Teaching Hospital, APHP, Paris (M. Decavèle, M. Pineton de Chambrun); Hôpital Tenon, Groupe Hospitalo-Universitaire Sorbonne University, APHP, Paris (A. Beurton); Centre Hospitalier Régional d’Orléans, Orléans, France (T. Kamel); Institut Gustave Roussy, Villejuif, France (A. Stoclin); Institut Paoli Calmettes, Marseille, France (D. Mokart); Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay, France (F. Bruneel); Cochin Teaching Hospital, APHP, Paris (C. Vigneron); Centre Hospitalier Universitaire d’Angers, Angers, France (A. Kouatchet); Hôpital Bicêtre, APHP, France (B. Henry); Dijon Bourgogne University Hospital, Dijon, France (J.-P. Quenot); Rouen University Hospital, Rouen, France (G. Jolly); Saint-André Hospital, Bordeaux, France (N. Issa); University Hospital of Caen, Caen, France (M. Bellal); Hôpitaux Universitaires de Strasbourg, Strasbourg, France (J. Poissy); Centre Hospitalier Intercommunal de Poissy Saint Germain, Poissy, France (C. Pichereau); Avicennes Hospital, APHP, Ile de France, France (J. Schmidt); University Hospital of Liege, Liege, Belgium (N. Layios); Lyon University Hospital, Lyon, France (M. Gaillet)

Main Article

Table 1

Baseline characteristics of patients in study of critically ill patients with visceral Nocardia infection, France and Belgium, 2004–2023*

Baseline characteristics Nocardiosis cases, n = 50
Age, y, median (IQR)
 59 (47–67)
Sex
M 39 (78)
F
 11 (22)
Charlson score, median (IQR) 4 (3–7)
Cardiovascular risk factors, median (IQR)
 2 (1–3)
Immunosuppression 46 (92)
Corticosteroids at admission 34 (68)
5–10 mg/d 5 (10)
>10 mg/d 29 (58)
Tacrolimus treatment 16 (32)
Mycophenolate mofetil treatment 12 (24)
Other conventional immunosuppressive drugs†
 5 (10)
Organ transplantation 18 (36)
Kidney 12 (24)
Heart 4 (8)
Liver 1 (2)
Lung
 1 (2)
Systemic autoimmune disease‡
 12 (24)
Hematologic malignancies 10 20)
Aggressive B cell lymphoma 6 (12)
Acute lymphoid leukemia 3 (6)
Acute myeloid leukemia
 1 (2)
No. lymphocytes/mm3, median (IQR) 552 (287–1,210)
Gamma globulin, g/L, median (IQR) 6 (4–10)
Trimethoprim/sulfamethoxazole prophylaxis 12 (24)

*Values are no. (%) except as indicated. IQR, interquartile range. †Azathioprine, n = 4 (8%); methotrexate, n = 1 (2%). ‡Connective tissue disease, n = 2; glomerulonephritis, n = 1; periarteritis nodos, n = 1; bullous pemphigoid, n = 1; Evans syndrome, n = 1; IgA vasculitis, n = 1; type 1 diabetes, n = 1; myasthenia gravis, n = 1; sarcoidosis, n = 1; chronic inflammatory demyelinating polyradiculoneuropathy, n = 1; inflammatory bowel disease, n = 1.

Main Article

Page created: December 21, 2023
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external